Breaking News Instant updates and real-time market news.

MDT

Medtronic

$92.33

0.74 (0.81%)

13:18
11/06/18
11/06
13:18
11/06/18
13:18

Medtronic says new data reinforce IN.PACT Admiral as 'durable, frontline option'

Medtronic said data presented in two late-breaking clinical trial presentations at the Vascular Interventional Advances 2018 conference reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon in patients with peripheral artery disease in the superficial femoral and popliteal arteries. "Since the entrance of DCBs into the market several years ago, we have seen a shift towards the use of this technology as a frontline therapy to treat patients with PAD. This is especially true of IN.PACT Admiral DCB, which has consistently proven to be one of the safest, most effective, and durable therapies in treating patients across the spectrum of femoral-popliteal disease. We are proud to have become the first company to share five-year data on a commercially-available DCB and the first to present outcomes from the largest pooled analysis in the peripheral space to-date. We believe this new evidence will give physicians the confidence that IN.PACT Admiral DCB is the preferred first line therapy for patients who suffer with femoral-popliteal disease," said Mark Pacyna, vice president and general manager of the Peripheral business in the Medtronic Cardiac & Vascular Group. "

MDT Medtronic
$92.33

0.74 (0.81%)

10/16/18
LEHM
10/16/18
INITIATION
LEHM
Barclays starts MedTech sector with Positive view
Barclays analyst Kristen Stewart last night initiated coverage of the MedTech sector with a Positive view. The analyst expects the MedTech market to grow 4%-5% "for the foreseeable future" and believes the recent increase in price-to-earnings multiples in the space is warranted given the improving fundamentals. Looking ahead, she thinks relative P/E multiples "should be at least maintained." Stewart initiated coverage on 12 stocks, with Overweight ratings on Abbott (ABT), Boston Scientific (BSX) Stryker (SYK) and Medtronic (MDT). The analyst put Underweight ratings on Baxter (BAX), Edwards Lifesciences (EW) and Zimmer Biomet (ZBH).
10/16/18
10/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abbott (ABT), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT) were initiated with an Overweight at Barclays, while Baxter (BAX), Edwards Lifesciences (EW), and Zimmer Biomet (ZBH) were initiated with an Underweight. 2. Expedia (EXPE) was initiated with an Outperform at Evercore ISI, while TripAdvisor (TRIP) was initiated with an In Line, and Booking Holdings (BKNG) was initiated with an In Line. 3. Facebook (FB) was initiated with a Buy at Loop Capital and Rosenblatt. 4. Snap (SNAP) initiated with a Hold at Loop Capital. 5. VF Corp. (VFC) initiated with a Neutral at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/05/18
PIPR
11/05/18
NO CHANGE
PIPR
Overweight
Globus Medical unlikely to be hurt by Medtronic approval, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien noted that Medtronic (MDT) and Mazor Robotics (MZOR) received FDA 510K approval late last week for their new Mazor X Stealth system. He believes that Medtronic is closing the technology gap with Globus Medical (GMED) with the Mazor X Stealth, but he still sees the latter in the lead and thinks new features that Globus intends to introduce this year will keep it there. O'Brien has Overweight ratings on both Globus Medical and Medtronic.
11/06/18
STFL
11/06/18
NO CHANGE
Target $70
STFL
Buy
Stifel still upbeat on IntriCon's long-term prospects after Q3 report
Stifel analyst Jonathan Block said IntriCon's (IIN) stock might see some selling pressure after the company's Q3 revenue of $30.1M came in modestly below his $30.5M forecast, but he remains upbeat on the company's long-term prospects given his view that it is still very early in the process of IntriCon benefiting from Medtronic's (MDT) 670G/690G product cycles. Block keeps a Buy rating and $70 price target on shares of IntriCon, which are down $9.77, or 22%, to $34.52 in morning trading.

TODAY'S FREE FLY STORIES

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:42
02/19/19
02/19
07:42
02/19/19
07:42
Hot Stocks
Noble Midstream sees adjusted EBITDA from partnership of at least $300M in 2020 »

Anticipates adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CSX

CSX

$72.52

0.91 (1.27%)

07:41
02/19/19
02/19
07:41
02/19/19
07:41
Downgrade
CSX rating change  »

CSX downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    May

HEXO

HEXO Corp

$5.57

0.17 (3.15%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Initiation
HEXO Corp initiated  »

HEXO Corp initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Downgrade
Windstream rating change  »

Windstream downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

AMSC

AMSC

$15.00

-0.8 (-5.06%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Conference/Events
AMSC management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Hot Stocks
Noble Midstream sees FY19 adjusted EBITDA $340M-$390M »

"Entering 2019, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

07:40
02/19/19
02/19
07:40
02/19/19
07:40
General news
Treasury Market Outlook: bond yields have dipped slightly lower amid risk-off flows »

Treasury Market Outlook:…

CEQP

Crestwood Equity

$32.82

-0.06 (-0.18%)

07:39
02/19/19
02/19
07:39
02/19/19
07:39
Earnings
Crestwood Equity sees FY19 net income $105M-$135M »

Sees FY 19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PODD

Insulet

$88.51

3.68 (4.34%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Recommendations
Insulet analyst commentary  »

Insulet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NWL

Newell Brands

$17.15

-4.55 (-20.97%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Recommendations
Newell Brands analyst commentary  »

Newell Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CEQP

Crestwood Equity

$32.82

-0.06 (-0.18%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Earnings
Crestwood Equity reports Q4 EPS 57c, may not compare to consensus 13c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

IRBT

iRobot

$119.34

4 (3.47%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Downgrade
iRobot rating change  »

iRobot downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPC

W.P. Carey

$75.16

-0.02 (-0.03%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Hot Stocks
W.P. Carey to invest $75M in food production facility in San Antonio »

W. P. Carey announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EBAY

eBay

$36.59

0.28 (0.77%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
eBay analyst commentary  »

eBay January trends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

MIDD

Middleby

$126.19

2.13 (1.72%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Hot Stocks
Middleby announces retirement of CEO Selim Bassoul »

The Middleby Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
PepsiCo analyst commentary  »

PepsiCo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

PATK

Patrick Industries

$47.06

2.01 (4.46%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
Patrick Industries analyst commentary  »

Patrick Industries price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SB

Safe Bulkers

$1.60

-0.01 (-0.62%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Earnings
Safe Bulkers reports Q4 adj. EPS 7c, consensus 8c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NXRT

NexPoint Residential

$38.40

0.13 (0.34%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Earnings
NexPoint Residential sees FY19 AFFO $2.16, consensus $2.24 »

Sees FY19 Same Store NOI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

DE

Deere

$158.99

-3.45 (-2.12%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Recommendations
Deere analyst commentary  »

Too early to write off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

07:34
02/19/19
02/19
07:34
02/19/19
07:34
Hot Stocks
Biohaven Pharmaceutical's verdiperstat receives FDA orphan drug designation »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$47.54

1.49 (3.24%)

07:34
02/19/19
02/19
07:34
02/19/19
07:34
Downgrade
Canopy Growth rating change  »

Canopy Growth downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NXRT

NexPoint Residential

$38.40

0.13 (0.34%)

07:33
02/19/19
02/19
07:33
02/19/19
07:33
Earnings
NexPoint Residential reports Q4 AFFO 47c, consensus 51c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PRIM

Primoris

$21.29

0.09 (0.42%)

07:33
02/19/19
02/19
07:33
02/19/19
07:33
Hot Stocks
Primoris announces solar award valued over $170M »

Primoris announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NBL

Noble Energy

$22.63

0.62 (2.82%)

07:33
02/19/19
02/19
07:33
02/19/19
07:33
Hot Stocks
Noble Energy sees Q1 sales volumes 321-336 MBoe/d »

The Company anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.